For management of anemia using ESA, initiation of ESA treatment in predialysis CKD patients is recommended when the Hb level is < 10 g/dL, and guidelines recommend that ESA is not used to maintain an Hb level > 11.5 g/dL [10]. The gene discussed is GSTM1; the disease is chronic kidney disease.